Microsoft and Meta's strong earnings reports that eased investor fears of an economic slowdown amid President Trump's tariffs ...

Eli Lilly on Thursday posted better-than-expected quarterly results, but CVS Health's decision to drop the company's obesity ...

Researchers in Dallas want to know if the class of drugs, GIP/GLP-1 receptor agonists, might be a secret weapon in the fight ...

She suggested I start taking the GLP-1 Zepbound through weekly injections, along with incorporating a healthy diet and ...

The companies, which have at times had an adversarial relationship, also said they would develop a roadmap to continue their ...